You are viewing an incomplete version of our website. Please click to reload the website as full version.

Aperçu des produits pour anti-RIP2 (RIP2) Anticorps

Full name:
anti-ROP Interactive Partner 2 Anticorps (RIP2)
Chez www.anticorps-enligne.fr sont 24 ROP Interactive Partner 2 (RIP2) Anticorps de 5 de différents fournisseurs disponibles. Un total de 24 RIP2 produits sont actuellement listés.
Synonymes:
2210420D18Rik, CARD3, CARDIAK, CCK, D4Bwg0615e, GIG30, RICK, RIP2
afficher tous les anticorps Gène GeneID UniProt
RIP2 192656 P58801
RIP2 8767 O43353
RIP2    

Afficher toutes les espèces

Afficher tous les synonymes

Réactivités les plus populaires pour anti-RIP2 (RIP2) Anticorps

Sélectionnez vos espèces et l'application

anti-Mouse (Murine) RIP2 Anticorps:

anti-Human RIP2 Anticorps:

anti-Rat (Rattus) RIP2 Anticorps:

Tous anti-RIP2 Anticorps disponible

Vous arrivez à notre recherche pré-filtrée.

anti-RIP2 Anticorps mieux référencés

  1. Human Polyclonal RIP2 Primary Antibody pour IHC (fro), WB - ABIN2476367 : Inohara, del Peso, Koseki, Chen, Núñez: RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. dans The Journal of biological chemistry 1998 (PubMed)
    Show all 3 references for ABIN2476367

Plus d’anticorps contre RIP2 partenaires d’interaction

Mouse (Murine) ROP Interactive Partner 2 (RIP2) interaction partners

  1. this study reveals that LRRK2 (Montrer LRRK2 Anticorps) is a new positive regulator of Rip2 (Montrer ARHGDIG Anticorps) and promotes inflammatory cytokine induction through the Nod1 (Montrer NOD1 Anticorps)/2-Rip2 (Montrer ARHGDIG Anticorps) pathway.

  2. that Rip2 modifies VEGF-induced signalling and vascular permeability in myocardial ischaemia

  3. Bacterial polysaccharide-responsive miR (Montrer MLXIP Anticorps)-150 and miR (Montrer MLXIP Anticorps)-143 RIPK2 (Montrer RIPK2 Anticorps) and TAK1 (Montrer NR2C2 Anticorps) to suppress NOD2 (Montrer NOD2 Anticorps)-induced immunomodulators.

  4. NOD2 (Montrer NOD2 Anticorps) downregulates colonic inflammation by IRF4 (Montrer IRF4 Anticorps)-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6 (Montrer TRAF6 Anticorps).

  5. RIPK2 (Montrer RIPK2 Anticorps) has a role in NOD signalling and in inflammatory cytokine production

  6. Rip2 (Montrer ARHGDIG Anticorps)-deficient tumors showed enhanced epithelial-to-mesenchymal transition, with elevated expression of zeb1 (Montrer ZEB1 Anticorps), zeb2 (Montrer ZEB2 Anticorps), twist, and snail (Montrer SNAI1 Anticorps) in the tumor microenvironment.

  7. data show that Nod1 (Montrer NOD1 Anticorps), Nod2 (Montrer NOD2 Anticorps) and Rip2 (Montrer ARHGDIG Anticorps) are not required for local chemokine (Montrer CCL1 Anticorps) production and neutrophil recruitment during CLP (Montrer HAPLN1 Anticorps)-induced sepsis, and they reinforce the importance of MyD88 (Montrer MYD88 Anticorps)-dependent signaling for initiation of a protective host response.

  8. Suggest that the Nod2 (Montrer NOD2 Anticorps)-Rip2 (Montrer ARHGDIG Anticorps) axis may contribute to the innate immune response of neutrophils against bacterial infection.

  9. Nod/Ripk2 (Montrer RIPK2 Anticorps) signaling in dendritic cells activates IL-17A (Montrer IL17A Anticorps)-secreting innate lymphoid cells and drives colitis in T-bet-/-.Rag2 (Montrer RAG2 Anticorps)-/- (TRUC) mice.

  10. SMS (Montrer SMS Anticorps) suppressed the activation of NF-kappaB (Montrer NFKB1 Anticorps) and receptor interacting protein-2/caspase-1 (Montrer CASP1 Anticorps).

Human ROP Interactive Partner 2 (RIP2) interaction partners

  1. this study reveals that LRRK2 (Montrer LRRK2 Anticorps) is a new positive regulator of Rip2 (Montrer ARHGEF28 Anticorps) and promotes inflammatory cytokine induction through the Nod1 (Montrer NOD1 Anticorps)/2-Rip2 (Montrer ARHGEF28 Anticorps) pathway.

  2. Together, the data demonstrate that the NOD2 (Montrer NOD2 Anticorps)-RIP2 (Montrer ARHGEF28 Anticorps) pathway is activated in murine and human visceral leishmaniasis and plays a role in shaping adaptive immunity toward a Th1 (Montrer TH1L Anticorps) profile.

  3. RIP2 (Montrer ARHGEF28 Anticorps) and RhoGDI (Montrer ARHGDIA Anticorps) bind to p75(NTR (Montrer NGFR Anticorps)) death domain at partially overlapping epitopes with over 100-fold difference in affinity, revealing the mechanism by which RIP2 (Montrer ARHGEF28 Anticorps) recruitment displaces RhoGDI (Montrer ARHGDIA Anticorps) upon ligand binding.

  4. that Rip2 modifies VEGF-induced signalling and vascular permeability in myocardial ischaemia

  5. Barettin has inhibitory activity against two protein kinases related to inflammation, namely the receptor-interacting serine/threonine kinase 2 (RIPK2 (Montrer RIPK2 Anticorps)) and calcium/calmodulin-dependent protein kinase (Montrer CAMK2 Anticorps) 1alpha (CAMK1alpha).

  6. RIPK1 (Montrer RIPK1 Anticorps) and RIPK2 (Montrer RIPK2 Anticorps) are targets of HIV-1 Protease activity during infection, and their inactivation may contribute to modulation of cell death and host defense pathways by HIV-1

  7. NOD2 (Montrer NOD2 Anticorps) downregulates colonic inflammation by IRF4 (Montrer IRF4 Anticorps)-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6 (Montrer TRAF6 Anticorps).

  8. RIP2 (Montrer ARHGEF28 Anticorps) protein, human is involved in human colon tumorigenesis and could be a predictive marker for colon carcinoma progression

  9. Changes in the expression levels of IRS1 (Montrer IRS1 Anticorps), IRS2 (Montrer IRS2 Anticorps), RIPK2 (Montrer RIPK2 Anticorps), RSPO1 (Montrer RSPO1 Anticorps), and DNA JC15 genes might contribute to the development of insulin (Montrer INS Anticorps) resistance and glucose intolerance in the obese boys.

  10. Data indicate that receptor-interacting protein (Montrer RIPK1 Anticorps) kinase 2 (Montrer PKC Anticorps) (RIP2 (Montrer ARHGEF28 Anticorps)) is an activator of the NF-kappa B (Montrer NFKB1 Anticorps) and c-Jun N-terminal kinase pathways.

RIP2 profil antigène

Antigen Summary

This gene encodes a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases. The encoded protein contains a C-terminal caspase activation and recruitment domain (CARD), and is a component of signaling complexes in both the innate and adaptive immune pathways. It is a potent activator of NF-kappaB and inducer of apoptosis in response to various stimuli.

Alternative names and synonyms associated with RIP2

  • receptor (TNFRSF)-interacting serine-threonine kinase 2 (Ripk2) anticorps
  • receptor-interacting serine-threonine kinase 2 (RIPK2) anticorps
  • 2210420D18Rik anticorps
  • CARD3 anticorps
  • CARDIAK anticorps
  • CCK anticorps
  • D4Bwg0615e anticorps
  • GIG30 anticorps
  • RICK anticorps
  • RIP2 anticorps

Protein level used designations for RIP2

receptor-interacting serine/threonine-protein kinase 2 , tyrosine-protein kinase RIPK2 , CARD-carrying kinase , CARD-containing IL-1 beta ICE-kinase , CARD-containing interleukin-1 beta-converting enzyme (ICE)-associated kinase , RIP-2 , growth-inhibiting gene 30 , receptor-interacting protein (RIP)-like interacting caspase-like apoptosis regulatory protein (CLARP) kinase , receptor-interacting protein 2

GENE ID SPECIES
192656 Mus musculus
8767 Homo sapiens
Fournisseurs de qualité sélectionnés pour anti-RIP2 (RIP2) Anticorps
Avez-vous cherché autre chose?